STERIS to Discuss Upcoming Financial Results
STERIS plc (NYSE: STE) is gearing up to host an important conference call where they will unveil their fiscal 2025 second quarter financial results. This significant event is set for a live broadcast at 9:00 a.m. ET on November 7. Investors and stakeholders can tune in for insights into the company's performance and strategies moving forward.
How to Participate in the Call
The conference call will be accessible through STERIS's dedicated investor relations website. Those who prefer to listen via phone can do so by dialing 1-833-535-2199 within the United States or 1-412-902-6776 for international access. Participants will need to request to join the call for STERIS plc specifically.
A Recap of Financial Performance
Leading up to the call, STERIS is expected to release a comprehensive press statement outlining their financial performance details shortly after the stock market closes on the preceding day, November 6. This release will provide an overview of various financial metrics and highlight critical changes that have occurred within the company over the reporting period.
Replay Information for Attendees
For those unable to join the live discussion, STERIS will offer a replay of the conference call starting at noon ET on the same day. Listeners can access the recorded call by utilizing the access code 6859931 and dialing the appropriate number based on their location.
About STERIS and Their Commitment to Health
STERIS is renowned for being a leading global provider of essential products and services aimed at enhancing patient care, focusing specifically on infection prevention. The company prides itself on helping foster a healthier and safer world by delivering innovative solutions tailored to healthcare and life sciences. Their dedication to this cause reflects in the wide array of services and products they offer, making a tangible difference in the industry.
Corporate Contact Information
Anyone seeking further information can reach out to Julie Winter, Vice President of Investor Relations and Corporate Communications. Interested parties are encouraged to utilize the following contact details:
Email: Julie_Winter@steris.com
Phone: +1.440.392.7245
Frequently Asked Questions
What is the purpose of the STERIS conference call?
The conference call aims to discuss the fiscal 2025 second quarter financial results and provide insights into the company’s performance.
When will the press release about the financial results be issued?
The press release detailing the financial results will be made available after the U.S. market closes on the day before the conference call.
How can I listen to the call if I miss it live?
You can listen to a replay of the conference call starting at noon ET on November 7 by calling the designated numbers and using the access code provided.
Who can I contact for more information about STERIS?
For additional inquiries, you can contact Julie Winter at +1.440.392.7245 or via email.
What industry does STERIS operate in?
STERIS operates primarily in the healthcare and life sciences sectors, focusing on products and services that prevent infection and support patient care.